251112-23-9

Basic information

• Product Name: (S)-3-tert-Butylcarbamoyl-4-((2R,3S)-2-hydroxy-3-{(S)-2-[3-(2-isopropyl-thiazol-4-ylmethyl)-3-methyl-ureido]-3-methyl-butyrylamino}-4-phenyl-butyl)-piperazine-1-carboxylic acid tert-butyl ester
• CAS NO: 251112-23-9
• Molecular Weight: 744.012
• Mol File: 251112-23-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-3-tert-Butylcarbamoyl-4-((2R,3S)-2-hydroxy-3-{(S)-2-[3-(2-isopropyl-thiazol-4-ylmethyl)-3-methyl-ureido]-3-methyl-butyrylamino}-4-phenyl-butyl)-piperazine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-tert-Butylcarbamoyl-4-((2R,3S)-2-hydroxy-3-{(S)-2-[3-(2-isopropyl-thiazol-4-ylmethyl)-3-methyl-ureido]-3-methyl-butyrylamino}-4-phenyl-butyl)-piperazine-1-carboxylic acid tert-butyl ester(251112-23-9)
• EPA Substance Registry System: (S)-3-tert-Butylcarbamoyl-4-((2R,3S)-2-hydroxy-3-{(S)-2-[3-(2-isopropyl-thiazol-4-ylmethyl)-3-methyl-ureido]-3-methyl-butyrylamino}-4-phenyl-butyl)-piperazine-1-carboxylic acid tert-butyl ester(251112-23-9)

Safety Data

• Hazardous Substances Data: 251112-23-9(Hazardous Substances Data)

Upstream product

• 154212-61-0 N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)-carbonyl)-L-valine 
• 159572-17-5 (S)-4-((2R,3S)-3-Amino-2-hydroxy-4-phenyl-butyl)-3-tert-butylcarbamoyl-piperazine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 251112-24-0 N'-[(1S)-1-[[[(1S,2R)-3-[(2S)-2-[[(1,1-Dimethylethyl)amino]carbonyl]-1-piperazinyl]-2-hydroxy-1-(phenylmethyl)propyl]amino]carbonyl]-2-methylpropyl]-N-methyl-N-[2-(1-methylethyl)-4-thiazolylmethyl]urea 

Relevant articles and documents

Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands

The 2-isopropyl thiazolyl group is a highly optimized P3 ligand for C2 symmetry-based HIV protease inhibitors, as exemplified in the drag ritonavir. Here we report that incorporation of this P3 ligand into a piperazine hydroxyethylamine series also yielded novel, highly potent inhibitors. In tissue culture assays, the presence of human serum was less deleterious to the activity of these inhibitors than to that of ritonavir. Furthermore, potent activity against ritonavir resistant HIV was observed.